Resolute Integrity™ RSINT35009UXRecalls & reported problems
Medtronic, Inc. · Stent RSINT35009UX MicroTrac 3.50X9RX · Class 3 · Implant
All models of Resolute Integrity (52)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169037090), received between Feb 16, 2017 and Jan 30, 2019 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Device Damaged by Another Device” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Device Damaged by Another Device1
- Device Dislodged or Dislocated1
- Difficult to Remove1
- Material Deformation1
Patient problems
- No Consequences Or Impact To Patient1
- Patient Problem/Medical Problem1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 30, 2019Difficult to Remove; Device Damaged by Another Device; Material Deformation; Difficult to Remove; Device Damaged by Another Device; Material Deformation
AN ATTEMPT WAS MADE TO USE ONE RESOLUTE INTEGRITY RX CORONARY DRUG ELUTING STENT TO TREAT A MODERATELY TORTUOUS, SEVERELY CALCIFIED LESION EXHIBITING 95% STENOSIS LOCATED IN THE MID RCA. THE DEVICE WAS INSPECTED WITH NO ISSUES. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES. THE LESION WAS PRE-DILATED. RESISTANCE WAS ENCOUNTERED WHEN ADVANCING THE DEVICE. EXCESSIVE FORCE WAS USED DURING DELIVERY. IT WAS REPORTED THAT WHILE ADVANCING THE STENT THROUGH SEVERE CALCIUM AND A NEWLY DEPLOYED STENT, THE RESOLUTE INTEGRITY ENCOUNTERED SEVERE RESISTANCE INSIDE THE STENT AND COULD NOT ADVANCE. THERE WERE TWO NON-MEDTRONIC GUIDE WIRES IN PLACE. THE DEVICE WAS PULLED BACK HOWEVER THE STENT BECAME CAUGHT INSIDE THE PREVIOUSLY DEPLOYED STENT AND POSSIBLY THE SECOND NON-MEDTRONIC GUIDE WIRE. THE RESOLUTE INTEGRITY STENT WAS PULLED BACK INTO THE GUIDE AND REMOVED WITH FORCE. IT WAS INDICATED THAT THE NON-MEDTRONIC GUIDE WIRE SEPARATED AND WRAPPED ON THE STENT BALLOON. IT WAS INDICATED THAT THE STENT UNRAVELED TO THE CORE WIRE. THE PATIENT IS REPORTED TO BE ALI VE WITHOUT INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8289089 ↗InjuryFeb 16, 2017Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PHYSICIAN WAS ATTEMPTING TO YOU A RESOLUTE INTEGRITY RX DRUG ELUTING STENT TO TREAT A MODERATELY CALCIFIED AND SEVERELY TORTUOUS MID LAD LESION EXHIBITING 90% STENOSIS. NO DAMAGE WAS NOTED TO THE DEVICE PACKAGING AND NO ISSUES NOTED REMOVING THE DEVICE FROM THE HOOP TRAY. NO ISSUES NOTED WHEN REMOVING THE PROTECTIVE SHEATH. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS NOT PERFORMED. THE PHYSICIAN PRE-DILATED THE LESION. DURING THE PROCEDURE, THE DEVICE PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. NO EXCESSIVE FORCE WAS USED DURING DELIVERY. INFLATION DEVICE REMAINED ON NEUTRAL PRESSURE DURING DELIVERY OF THE DEVICE. IT IS REPORTED THAT THE RESOLUTE CAUGHT ON A STRUT AND DISLODGED WHEN THE PHYSICIAN PULLED BACK DEVICE. STENT DISLODGEMENT OCCURRED DURING DELIVERY TO/AT LESION. THE PHYSICIAN CRUSHED THE STENT AGAINST THE DISTAL LAD WALL WITH ANOTHER STENT.
Patient problems: Patient Problem/Medical Problem
MAUDE report 6335114 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page